Are organoids and organ-on-chip the future of scientific research?

With the right technology the answer is yes! Our CSO, Silvia Scaglione, introduces in this webinar the potentiality of the React4life’s patented core technologies MIVO, the fluid-dynamic multi-chamber device that allows to recreate in lab human complex systems for improving the in vitro 3D tissue culture and carrying out reliable molecule/drug testing.

Who it is for: Scientists and innovators of pharma companies, testing companies, CRO and research entities (universities and R&D centers).

About the speaker

Dr. Silvia Scaglione studied Biomedical Engineering at the University of Genova where she also obtained her PhD in 2005.  She was visiting scientist at the Univ. Hospital of Basel at the Tissue Engineering Lab leaded by Ivan Martin. She was post-doc associate at Advanced Biotechnology Center in Genoa for 5 years, and then appointed Researcher at National Research Council of Italy since 2010. She is currently author of more than 60 peer-reviewed papers on international journals and inventor on 7 patent applications. She is chief scientist of Reac4life, where she leads a R&D team involved in 3D tissue models, absorption assays and drug testing. She is also coordinator of a H2020-Future Emerging Technology (FET-OPEN) project about a spontaneous breast-to-bone in vitro metastasis model.